Publications by authors named "Matteo Muto"

Claim this Profile
P
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer.
Vincenzo Iorio, Pietro Delia, Angela Pia Solazzo, Ivan Fazio, Antonino Daidone, Matteo Muto, Paolo Muto

Anticancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers.
Luca Bergamaschi, Maria Giulia Vincini, Mattia Zaffaroni, Matteo Pepa, Ilaria Angelicone, Matteo Muto, Paolo Muto

Support Care Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer.
Biagio Barone, Luigi Napolitano, Francesco Paolo Calace, Dario Del Biondo, Giorgio Napodano, Matteo Muto

Diagnostics (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life and Psychological Distress among Patients with Small Renal Masses.
Liliana Vartolomei, Andrei Cotruș, Camelia Stanciu, Cristian Delcea, Marco Tozzi, Matteo Muto

J Clin Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study.
Marcello Serra, Fortuna De Martino, Federica Savino, Valentina D'Alesio, Cecilia Arrichiello, Matteo Muto, Paolo Muto

Life (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
Matteo Ferro, Daniela Terracciano, Gennaro Musi, Ottavio de Cobelli, Mihai Dorin Vartolomei, Matteo Muto

Urol Int· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy.
Matteo Ferro, Octavian Sabin Tătaru, Gennaro Musi, Giuseppe Lucarelli, Abdal Rahman Abu Farhan, Matteo Muto

Diagnostics (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study.
Matteo Ferro, Michele Marchioni, Giuseppe Lucarelli, Mihai D Vartolomei, Francesco Soria, Matteo Muto

Minerva Urol Nephrol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.
Matteo Ferro, Ottavio de Cobelli, Mihai Dorin Vartolomei, Giuseppe Lucarelli, Felice Crocetto, Matteo Muto

Int J Mol Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis.
Matteo Ferro, Ottavio de Cobelli, Gennaro Musi, Giuseppe Lucarelli, Daniela Terracciano, Tommaso Muto, Matteo Muto

Front Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer.
Matteo Ferro, Marina Di Mauro, Sebastiano Cimino, Giuseppe Morgia, Giuseppe Lucarelli, Matteo Muto

Transl Androl Urol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soft tissue necrosis in patients treated with transoral robotic surgery and postoperative radiotherapy: preliminary results.
Daniela Alterio, Marta Tagliabue, Matteo Muto, Stefano Zorzi, Stefania Volpe

Tumori· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer.
Marcello Serra, Gianluca Ametrano, Valentina Borzillo, Maria Quarto, Matteo Muto, Muto Paolo

Medicine (Baltimore)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?
Gian Maria Busetto, Angelo Porreca, Francesco Del Giudice, Martina Maggi, Daniele D'Agostino, Matteo Muto

Urol Int· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond PSA: The Role of Prostate Health Index (phi).
Matteo Ferro, Ottavio De Cobelli, Giuseppe Lucarelli, Angelo Porreca, Gian Maria Busetto, Matteo Muto

Int J Mol Sci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of radiation therapy and systemic therapies in elderly with breast cancer.
Valerio Nardone, Sara Falivene, Francesca Maria Giugliano, Marcella Gaetano, Pasqualina Giordano, Matteo Muto

Transl Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era.
Alessia Spagnuolo, Matteo Muto, Fabio Monaco, Giuseppe Colantuoni, Cesare Gridelli

Transl Lung Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.
Francesco Cellini, Stefania Manfrida, Francesco Deodato, Savino Cilla, Ernesto Maranzano, Matteo Muto, Paolo Muto

Trials· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials.
Matteo Ferro, Giuseppe Di Lorenzo, Ottavio de Cobelli, Dario Bruzzese, Piero Pignataro, Matteo Muto

World J Urol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.
Matteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, Francesco Cantiello, Abdal Rahman Abu Farhan, Matteo Muto

World J Urol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiation therapy for mediastinal lymph node metastases: how do we fly in a 'no-fly zone'?
Barbara Alicja Jereczek-Fossa, Matteo Muto, Stefano Durante, Annamaria Ferrari, Gaia Piperno

Acta Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer.
Matteo Ferro, Giuseppe Di Lorenzo, Carlo Buonerba, Giuseppe Lucarelli, Giorgio Ivan Russo, Matteo Muto

J Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosurgery and stereotactic radiotherapy with cyberknife system for meningioma treatment.
Rossella Di Franco, Valentina Borzillo, Vincenzo Ravo, Sara Falivene, Francesco Jacopo Romano, Matteo Muto, Paolo Muto

Neuroradiol J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes.
Barbara Alicja Jereczek-Fossa, Giuseppe Fanetti, Cristiana Fodor, Delia Ciardo, Luigi Santoro, Matteo Muto

Clin Genitourin Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External radiotherapy for breast cancer in the elderly.
Francesca Maria Giugliano, Sara Falivene, Emanuela Esposito, Rossella Di Franco, Matteo Muto, Paolo Muto

Aging Clin Exp Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis